Recent Headlines
A CDC advisory panel is grappling with the best way to “do no harm” regarding Johnson & Johnson’s COVID-19 vaccine and its risk of blood clots.
-
Why might some COVID-19 vaccines pose a small risk of blood clots while others don’t? Scientists suspect it’s related to their use of adenoviruses.
-
Researchers are developing vaccines that could be taken as a capsule, a dissolvable tablet or a nasal spray. But the barriers to success are high.
-
The goal is to have a pediatric vaccine available for all ages from 6 months to adulthood
U.S. health advisors told the government that they need more evidence to decide whether a handful of unusual blood clots were linked to the shot — and if so, how big the potential risk is.
Reports of blood clots among those who got Johnson & Johnson’s COVID-19 vaccine may make some recipients anxious. Here’s how to handle those feelings.
Two COVID-19 vaccines have now been linked to a risk of developing blood clots. Scientists don’t know whether the vaccines are to blame.
The Centers for Disease Control and Prevention extended its eviction moratorium through the end of June. There were scientific reasons for doing so.
U.S. health officials say women seeking an abortion pill will not be required to visit a doctor’s office or clinic during the COVID-19 pandemic.
Patrick Radden Keefe’s much-anticipated “Empire of Pain” lays it all bare
We explain what vaccine passports are, how they work, where they’ve been implemented, and why some people object to them.
Up to 60 countries may be stalled at the first shots of their COVID-19 vaccinations because nearly all deliveries are blocked until as late as June.
Health news, ideas, advice and commentary.
Most Read
-
Why might some COVID-19 vaccines pose a small risk of blood clots while others don’t? Scientists suspect it’s related to their use of adenoviruses.
-
A lot of things are different when you’re in the midst of a global pandemic. A case in point: How federal regulators scrutinize and authorize new vaccines.
-
The side effects of a second shot of COVID-19 vaccine are a sign that it’s providing more vigorous, long-lasting protection against the coronavirus.
New versions of COVID-19 vaccines are now being tested in case they ever are needed to protect against mutated versions of the virus.
With coronavirus cases and related hospitalizations climbing nationwide, is California also headed for a fourth wave in the COVID-19 pandemic?
More Coverage
A past coronavirus infection may eliminate the need for a second dose of COVID-19 vaccine, a growing body of evidence suggests.
The COVID-19 death toll in California represents 10.7% of all such deaths nationwide. California is home to about 12% of Americans.
One-third of COVID-19 survivors were diagnosed with a psychiatric or neurological condition within six months of being infected with the coronavirus.
Two COVID-19 vaccines are likely to be protective against a rapidly spreading variant of the SARS-Cov-2 virus that arose in California, a study finds.
After the EU cites a ‘possible link’ between the AstraZeneca vaccine and rare blood clots, British authorities say some adults should get a different shot.
The heavy concentration of new coronavirus cases in just five states is putting pressure on the government to consider adjusting vaccine distribution.
New U.S. research shows most kids with a serious inflammatory illness called MIS-C linked to the coronavirus were symptom-free or had mild infections.
Covid-19 Vaccines
While China pushes a complacent population toward vaccination, a health official’s suggestion to mix vaccines broaches sensitive political territory.
-
More than half of Californians 18 and older have been at least partially vaccinated, according to CDC data.
-
With everyone 16 and older now eligible to get vaccinated, Riverside County health officials expect herd immunity to COVID-19 in eight to 10 weeks.
-
California removes the last barrier to widespread adult access to COVID-19 vaccines, though getting an appointment may still take some patience.
-
Among communities with at least 5,000 residents, those that saw the largest relative increases in their vaccination rates over a weeks-long stretch ending Monday were lower-income areas with predominantly non-white populations.
More Coverage
-
A doctor and a public health student each say more context is needed to understand the decision to temporarily suspend vaccination with the Johnson & Johnson shot.
More headlines
-
Lose it? Laminate it? Post it on Instagram? Some dos and don’ts for your vaccination card, the most exciting piece of paper you’ll get this year.
-
Results from two sets of experiments in Europe and the U.S. are creating cracks in the 50-year-old rulebook of the universe called the Standard Model.
-
A top official at Europe’s drugs regulator says there’s a link between AstraZeneca’s COVID-19 vaccine and a handful of cases of blood clots.
-
Vermont gave Black adults and people from other minority communities priority status for COVID-19 vaccinations. It joined Montana, which did so in January.
-
German officials have decided to limit the use of AstraZeneca’s coronavirus vaccine in people younger than 60 after more unusual blood clots were reported.
-
Pfizer says its vaccine works well for children as young as 12, raising hopes for the effectiveness of inoculations before the new school year.
-
The Easter Sunday holiday is going be a big test of whether California can avoid another COVID-19 spike, experts say.
-
The U.S. government’s first look at the real-world use of COVID-19 vaccines found their effectiveness was nearly as robust as in controlled studies.
-
With COVID-19 vaccines becoming more and more available, it’s hard for some people not to feel left out.
-
A new study shows that even a coronavirus variant that’s built to transmit won’t get very far if it doesn’t have the good fortune of meeting a superspreader.
-
In the first six months of the pandemic, potentially avoidable hospitalizations plummeted for white Angelenos but fell hardly at all among Black residents, reflecting a disparity in access to outpatient care.
Get our free Coronavirus Today newsletter
Sign up for the latest news, best stories and what they mean for you, plus answers to your questions.
You may occasionally receive promotional content from the Los Angeles Times.